Publications by authors named "A R Sherman"
Background: Babesiosis poses significant risks of adverse outcomes in individuals with immunocompromising conditions (IC) and asplenia/hyposplenia (AH). This study compares clinical outcomes between these vulnerable groups and immunocompetent patients.
Methods: A multicenter retrospective cohort study included adult patients with laboratory-confirmed babesiosis from 2009 to 2023.
Background: Mounting evidence suggests that mitochondria respond to psychosocial stress. Recent studies suggest mitochondrial DNA (mtDNA) deletions may be increased in some psychiatric disorders, but no studies have examined early-life stress (ELS) and mtDNA deletions. In this study, we assessed mtDNA deletions in peripheral blood mononuclear cells of medically healthy young adults with and without ELS.
View Article and Find Full Text PDFFuranocoumarins (FCs) are plant defence compounds derived from the phenylpropanoid pathway via the coumarin umbelliferone that harbour some therapeutic benefits yet are the underlying cause of 'grapefruit-drug interactions' in humans. Most of the pathway genes have not been identified in citrus. We employed a genetic/Omics approach on citrus ancestral species and F1 populations of mandarin × grapefruit and mandarin × pummelo.
View Article and Find Full Text PDFArticle Synopsis
- The introduction discusses challenges in achieving flat closure during oncologic mastectomy in obese patients and introduces the angel wing (AW) technique as a solution.
- A retrospective study at an academic center evaluated the safety of the AW technique by analyzing postoperative arm lymphedema (AL) and decreased range of motion (dROM) in patients who underwent mastectomy with and without this technique.
- Results showed no significant difference in the incidence of AL or dROM between the AW and non-AW groups, suggesting that the AW technique is a safe option for achieving effective surgical outcomes in obese patients postmastectomy.
Background: Most patients with a pediatric rheumatic disease are at increased risk of influenza due to immunosuppressive medication use. Despite initial quality improvement efforts, our influenza vaccination rate plateaued at 72%, which prompted a survey of patients and families to assess provider vaccine recommendations, influenza knowledge, and barriers to influenza vaccination.
Methods: Patients on immunosuppressive medication or their parent were eligible to complete a survey between July 2019 and January 2020.